Prescribing Trends of Glucose-Lowering Medications Near End of Life Among Adults With Type 2 Diabetes: A Cohort Study
Diabetes Care · 2025
DOI: 10.2337/dc24-1795 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Diabetes Care, 2025. Verfasst von Alexander Kutz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypoglycemic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, Novo Nordisk, NIA NIH HHS.
Themen: Diabetes mellitus, Palliativpflege
Abstract (Originalsprache)
OBJECTIVE To assess prescribing trends of glucose-lowering medications in the last year of life among older adults with type 2 diabetes (T2D) and explore whether frailty is associated with differential prescribing. RESEARCH DESIGN AND METHODS In this observational cohort study of Medicare beneficiaries aged ≥67 years (2015–2019) with T2D, we assessed temporal trends in prescribing a glucose-lowering medication, stratified by frailty. The main outcome included glucose-lowering medication fills within 1 year of death. RESULTS Among 975,407 community-dwelling Medicare beneficiaries with T2D, the use of glucose-lowering medications within 1 year of death slightly increased from 71.4% during the first 6-month period in 2015 to 72.9% (standardized mean difference [SMD] −0.03) during the second 6-month period in 2019. The most pronounced increase in use was observed for metformin (40.7% to 46.5%, SMD −0.12), whereas the largest decrease was observed for sulfonylureas (37.0% to 31.8%, SMD 0.11). Overall glucose-lowering medication use decreased from 66.1% in the 9 to 12 months before death to 60.8% in the last 4 months of life (SMD 0.11; P < 0.01), driven by reduced noninsulin medication use. The use of short-acting and long-acting insulin both increased near death, with frailer individuals more likely to receive insulin. Sodium–glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists, although less common, became more frequent in more recent years. CONCLUSIONS The use of glucose-lowering medications declined in the last year of life, mainly due to reduced noninsulin use. Insulin use increased near death, particularly among frailer individuals, highlighting the need for careful end-of-life management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
- Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, MA.
- Division of Gerontology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA.
- Joslin Diabetes Center, Harvard Medical School, Boston, MA.
- Beth Israel Deaconess Medical Center, Boston, MA.
ORCID-Profile: Alexander Kutz, Medha N Munshi, Elisabetta Patorno
Förderung
- the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
- Novo Nordisk
- NIA NIH HHS
- NIDDK NIH HHS
- FDA HHS
- Patient Centered Outcomes Research Institute
- Swiss National Science Foundation
- the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Zitieren
APA
Kutz, A., Kim, D. H., Liu, J., Munshi, M. N., & Patorno, E. (2025). Prescribing Trends of Glucose-Lowering Medications Near End of Life Among Adults With Type 2 Diabetes: A Cohort Study. Diabetes Care. https://doi.org/10.2337/dc24-1795
Vancouver
Kutz A, Kim DH, Liu J, Munshi MN, Patorno E. Prescribing Trends of Glucose-Lowering Medications Near End of Life Among Adults With Type 2 Diabetes: A Cohort Study. Diabetes Care. 2025. doi:10.2337/dc24-1795
BibTeX
@article{Kutz2025,
author = {Kutz, Alexander and Kim, Dae Hyun and Liu, Jun and Munshi, Medha N and Patorno, Elisabetta},
title = {Prescribing Trends of Glucose-Lowering Medications Near End of Life Among Adults With Type 2 Diabetes: A Cohort Study},
journal = {Diabetes Care},
year = {2025},
doi = {10.2337/dc24-1795}
}
EUVIMED